Nilsine Partners
EW icon

Nilsine Partners’s Edwards Lifesciences EW Stock Holding History

Nilsine Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$826K Buy
9,566
+1,125
+13% +$100K 0.06% 256
2026
Q2 		$764K Buy
8,441
+673
+9% +$56.4K 0.05% 256
2026
Q1 		$648K Buy
7,768
+2,958
+61% +$244K 0.05% 258
2025
Q4 		$410K Buy
4,810
+1,087
+29% +$89.2K 0.04% 296
2025
Q3 		$290K Buy
3,723
+981
+36% +$76.6K 0.03% 332
2025
Q2 		$214K Buy
+2,742
New +$204K 0.02% 363

Other funds holding EW

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mirova US
Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Nilsine Partners's EW Position: Q3 2026 in Review

Nilsine Partners increased its Edwards Lifesciences (EW) stake by 13% in Q3 2026, buying an estimated $100K and bringing the position to 9,566 shares worth $826K. The position accounts for 0.06% of the portfolio, ranked #256.

Nilsine Partners first reported a position in EW in Q2 2025 and has held it in 6 quarters since. 719 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Nilsine Partners held 9,566 shares of Edwards Lifesciences worth $826K as of Q3 2026.
  • Nilsine Partners bought 1,125 Edwards Lifesciences shares in Q3 2026, an estimated $100K.
  • Edwards Lifesciences made up 0.06% of Nilsine Partners's portfolio in Q3 2026, its #256 holding.
  • Nilsine Partners first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 6 quarters since.
  • 719 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.